News

John Theurer Cancer Center First NJ Site Certified to offer CAR-T Cell Cancer Therapy

Breakthrough gene therapy for B-cell lymphoma now available at Hackensack University Medical Center

John Theurer Cancer Center at Hackensack Meridian Health Hackensack University Medical Center is among limited U.S. sites, and the only hospital in New Jersey certified to offer Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded or who have relapsed after at least two other kinds of treatment.

Read full press release on hackensackmeridianhealth.org.